Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.
Gammeri E, Arena A, D'Anneo R, La Grutta S. Gammeri E, et al. Among authors: la grutta s. Allergol Immunopathol (Madr). 2005 Jul-Aug;33(4):221-3. doi: 10.1157/13077747. Allergol Immunopathol (Madr). 2005. PMID: 16045861 Clinical Trial.
BACKGROUND: The safety and good tolerability of sublingual immunotherapy (SLIT) has already been proved in allergic patients, but only one study has investigated the occurrence of immediate adverse reactions in allergic patients after a 2-hour ultra-rush regimen of SLIT performed …
BACKGROUND: The safety and good tolerability of sublingual immunotherapy (SLIT) has already been proved in allergic patients, but only one s …
Safety and tolerability of ultra-Rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma.
Gammeri E, Arena A, D'Anneo R, La Grutta S. Gammeri E, et al. Among authors: la grutta s. Allergol Immunopathol (Madr). 2005 May-Jun;33(3):142-4. doi: 10.1157/13075710. Allergol Immunopathol (Madr). 2005. PMID: 15946626 Clinical Trial.
BACKGROUND: The safety and good tolerability of sublingual immunotherapy (SLIT) has already been proved in allergic patients, but only one study has investigated the occurrence of immediate adverse reactions in allergic patients after a 2-hour ultra-rush regimen of SLIT performed …
BACKGROUND: The safety and good tolerability of sublingual immunotherapy (SLIT) has already been proved in allergic patients, but only one s …
Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S, Arena A, D'Anneo WR, Gammeri E, Leonardi S, Trimarchi A, Platania D, La Rosa M. La Grutta S, et al. Eur Ann Allergy Clin Immunol. 2007 Feb;39(2):40-4. Eur Ann Allergy Clin Immunol. 2007. PMID: 17441414 Clinical Trial.
Thus we decided to evaluate whether it can reduce the allergic inflammation and improve the clinical symptoms in comparison to pharmacotherapy. ...An evaluation of the nasal eosinophils was also performed at the same times. RESULTS: There was a greater reduction of …
Thus we decided to evaluate whether it can reduce the allergic inflammation and improve the clinical symptoms in comparison to pharma …
Feedback